Metabolic Surgery and Class 1 Obesity (< 35 kg/m
BMI < 35 kg/m2
Bariatric surgery
Class 1 obesity
Diabetes remission
Diabetes surgery
Laparoscopic gastric bypass
Latino
Metabolic surgery
Mexican
Mexico
Obesity
Journal
Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
25
10
2020
accepted:
08
02
2021
revised:
28
01
2021
pubmed:
19
2
2021
medline:
21
5
2021
entrez:
18
2
2021
Statut:
ppublish
Résumé
Metabolic surgery for managing class 1 obesity and type 2 diabetes mellitus has recently gained popularity. The Latino population presents high rates of these diseases. Reports on surgical outcomes in this population are scarce. Prospective study with Mexican patients diagnosed with diabetes and class 1 obesity submitted to Roux-en-Y gastric bypass. The objective was to determine short-, mid-, and long-term outcomes (weight loss, metabolic, morbidity, and diabetes remission). Sub-analysis was included, based on preoperative usage of one (group A) or more (group B) oral hypoglycemic agents ± insulin. Fifty-one patients with a mean body mass index of 33.1 ± 1.9 kg/m Gastric bypass is a safe and effective metabolic surgery that results in excellent mid- and long-term results among Mexicans. Patients using one drug preoperatively showed improved results and remission rates, which underscores the importance of intervening in the early stages of the disease. Clinical Trials identifier: NCT04595396 ( www.ClinicalTrials.gov ).
Identifiants
pubmed: 33598844
doi: 10.1007/s11695-021-05275-3
pii: 10.1007/s11695-021-05275-3
doi:
Banques de données
ClinicalTrials.gov
['NCT04595396']
Types de publication
Clinical Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2401-2409Références
Zubiaga L, Vilallonga R, Ruiz-Tovar J, et al. Importance of the gastrointestinal tract in type 2 diabetes. Metabolic surgery is more than just incretin effect. Cir Esp. 2018;96:537–45.
Alegre-Díaz J, Herrington W, López-Cervantes M, et al. Diabetes and cause-specific mortality in Mexico City. N Engl J Med. 2016;375:1961–71.
Barquera S, Hernández-Barrera L, Trejo B, et al. Obesidad en México, prevalencia y tendencias en adultos. Ensanut 2018-19. Salud Publica Mex. 2020;62:682–92.
Sheng B, Truong K, Spitler H, et al. The long-term effects of bariatric surgery on type 2 diabetes remission, microvascular and macrovascular complications, and mortality: a systematic review and meta-analysis. Obes Surg. 2017;27:2724–32.
Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by International Diabetes Organizations. Obes Surg. 2017;27:2–21.
Sudlow AC, Le Roux CW, Pournaras DJ. Long-term outcomes of bariatric surgery in patients with diabetes. Expert Rev Endocrinol Metab. Taylor & Francis. 2020;00:1–6.
Herrera MF, García-García E, Arellano-Ramos JF, et al. Metabolic surgery for the treatment of diabetes mellitus positioning of leading medical associations in Mexico. Obes Surg. 2018;28:3474–83.
Rubio-Almanza M, Hervás-Marín D, Cámara-Gómez R, et al. Does metabolic surgery lead to diabetes remission in patients with BMI < 30 kg/m2?: a meta-analysis. Obes Surg. 2019;29:1105–16.
Ji G, Li P, Li W, et al. The effect of bariatric surgery on Asian patients with type 2 diabetes mellitus and body mass index < 30 kg/m2: a systematic review and meta-analysis. Obes Surg. 2019;29:2492–502.
Hussain A. The effect of metabolic surgery on type 1 diabetes: meta-analysis. Arch Endocrinol Metab. 2018;62:172–8.
pubmed: 29641734
Baskota A, Li S, Dhakal N, et al. Bariatric surgery for type 2 diabetes mellitus in patients with BMI <30 kg/m2: a systematic review and meta-analysis. PLoS One. 2015;10:1–14.
Cummings DE, Cohen RV. Bariatric/metabolic surgery to treat type 2 diabetes in patients with a BMI <35 kg/m2. Diabetes Care. 2016;39:924–33.
doi: 10.2337/dc16-0350
Espinosa O, Pineda O, Maydón HG, et al. Type 2 diabetes mellitus outcomes after laparoscopic gastric bypass in patients with BMI <35 kg/m 2 using strict remission criteria: early outcomes of a prospective study among Mexicans. Surg Endosc. 2018;32:1353–9.
doi: 10.1007/s00464-017-5815-3
American Diabetes Association. Standards of medical care in diabetes–2013. Diabetes Care. 2013;36(Suppl 1):S11-66.
Summary of Revisions: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020 Jan;43(Suppl 1):S4-S6
Brethauer SA, Kim J, El Chaar M, et al. ASMBS Clinical Issues Committee. Standardized outcomes reporting in metabolic and bariatric surgery. Surg Obes Relat Dis. 2015 May-Jun;11(3):489-506.
Jans A, Näslund I, Ottosson J, et al. Duration of type 2 diabetes and remission rates after bariatric surgery in Sweden 2007-2015: A registry-based cohort study. PLoS Med. 2019;16:1–13.
Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care. 2009;32:2133–5.
Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care. 2016;39:861–77.
Zerrweck-Lopez C. The origin of the “simplified gastric bypass.”. Cir Cir (English Ed). 2015;83:87–8.
Guilbert L, Ortiz CJ, Espinosa O, et al. Metabolic syndrome 2 years after laparoscopic gastric bypass. Int J Surg. 2018 Apr;52:264-268.
Wu GZ, Cai B, Yu F, et al. Meta-analysis of bariatric surgery versus non-surgical treatment for type 2 diabetes mellitus. Oncotarget. 2016;7:87511–22.
Ribaric G, Buchwald JN, McGlennon TW. Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: a systematic review and meta-analysis. Obes Surg. 2014;24:437–55.
doi: 10.1007/s11695-013-1160-3
Yan G, Wang J, Zhang J, et al. Long-term outcomes of macrovascular diseases and metabolic indicators of bariatric surgery for severe obesity type 2 diabetes patients with a meta-analysis. PLoS One. 2019;14:1–16.
Pereyra-García Castro FM, Oliva García JG, García Nuñez MA, et al. Efficacy in type 2 diabetes mellitus remission in patients undergoing bariatric surgery. Endocrinol Diabetes Nutr. 2019;66:56–61.
Billeter AT, Eichel S, Scheurlen KM, et al. Meta-analysis of metabolic surgery versus medical treatment for macrovascular complications and mortality in patients with type 2 diabetes. Surg Obes Relat Dis. 2019;15:1197–210.
Huang ZP, Guo Y, Liu CQ, et al. The effect of metabolic surgery on nonobese patients (BMI<30 kg/m2) with type 2 diabetes: a systematic review. Surg Obes Relat Dis. Elsevier Inc. 2018;14:810–20.
Park CH, Nam SJ, Choi HS, et al. Comparative efficacy of bariatric surgery in the treatment of morbid obesity and diabetes mellitus: a systematic review and network meta-analysis. Obes Surg. 2019;29:2180–90.
Gu L, Huang X, Li S, et al. A meta-analysis of the medium- And long-term effects of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass. BMC Surg. 2020;20:1–10.
Sha Y, Huang X, Ke P, et al. Laparoscopic Roux-en-Y gastric bypass versus sleeve gastrectomy for type 2 diabetes mellitus in nonseverely obese patients: a systematic review and meta-analysis of randomized controlled trials. Obes Surg. 2020;30:1660–70.
Pucci A, Tymoszuk U, Cheung WH, et al. Type 2 diabetes remission 2 years post Roux-en-Y gastric bypass and sleeve gastrectomy: the role of the weight loss and comparison of DiaRem and DiaBetter scores. Diabet Med. 2018;35:360–7.
Aron-Wisnewsky J, Sokolovska N, Liu Y, et al. The advanced-DiaRem score improves prediction of diabetes remission 1 year post-Roux-en-Y gastric bypass. Diabetologia. 2017;60:1892–902.
Dicker D, Golan R, Aron-Wisnewsky J, et al. Prediction of long-term diabetes remission after RYGB, sleeve gastrectomy, and adjustable gastric banding using DiaRem and advanced-DiaRem Scores. Obes Surg. 2019;29:796–804.
Herrera A, León A, Rodríguez FM, et al. Type 2 diabetes mellitus remission models following laparoscopic gastric bypass: a 4-model analysis in a Latino population. Obes Surg. 2021;31(2):544–53.
Rubio-Almanza M, Cámara-Gómez R, Merino-Torres JF. Obesity and type 2 diabetes: Also linked in therapeutic options. Endocrinol Diabetes Nutr. 2019 Mar;66(3):140-149
Pournaras DJ, le Roux CW. Type 2 diabetes: multimodal treatment of a complex disease. Lancet. 2015 Sep 5;386(9997):936-7.
Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2015 Sep 5;386(9997):964-73.